With the baseline secretion rates, the model predicts that the pro-angiogenic factors (VEGF and FGF2) and anti-angiogenic factors (TSP1 and PF4) have significantly different distribution patterns in tumor tissue (Figure 3). This evidence concerns the gene FGF2 and neoplasm.